EGFR and colorectal carcinoma: Unfortunately, although Vitamin C is under clinical trials in combination with the anti-EGFR panitumumab in WT KRAS patients, no clinical trials targeting both metabolism and EGFR have been performed for KRAS-mutated CRC patients so far.